Literature DB >> 2428939

Myelin-associated glycoprotein shares an antigenic determinant with a glycoprotein of human melanoma cells.

A B Noronha, J R Harper, A A Ilyas, R A Reisfeld, R H Quarles.   

Abstract

A sulfated 100K-dalton glycoprotein has been shown to be released into the culture medium of melanoma cells. Monoclonal antibodies 10C5 and 11B5, which were raised to human melanoma cells, as well as HNK-1 bind to this glycoprotein. It is shown here that mouse anti-myelin-associated glycoprotein (MAG) carbohydrate antibodies raised to human MAG and a human IgM paraprotein associated with neuropathy also bind to the same 100K molecule. However, anti-MAG antibodies recognizing peptide epitopes do not appear to react with this glycoprotein of melanoma cells, a result suggesting that its similarity to MAG is restricted to shared carbohydrate moieties. The anti-melanoma antibodies (10C5 and 11B5) resemble HNK-1 in binding to MAG and to some 19-28K-dalton glycoproteins and sulfated, glucuronic acid-containing sphingoglycolipids of the peripheral nervous system (PNS). In addition, the anti-melanoma antibodies cross-react with neural cell adhesion molecule (N-CAM), an observation emphasizing the shared antigenicity between MAG and other adhesion molecules. The results demonstrate that the anti-melanoma antibodies fall into a class of monoclonal antibodies (including HNK-1, human IgM paraproteins associated with neuropathy, anti-human MAG antibodies, and L2 antibodies) that are characterized by reactivity against related carbohydrate determinants shared by human MAG, N-CAM, and several protein and lipid glycoconjugates of the PNS.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428939     DOI: 10.1111/j.1471-4159.1986.tb00795.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  Chronic inflammatory polyneuropathy revealing malignant melanoma.

Authors:  A Rousseau; F Salachas; M Baccard; J Y Delattre; M Sanson
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

2.  Chronic idiopathic demyelinating polyneuropathy (CIDP) associated with Kaposi's sarcoma.

Authors:  Yahya Celik; Nilda Turgut; Burhan Turgut; Gülsüm E Pamuk; Muzaffer Demir
Journal:  J Neurooncol       Date:  2006-06-23       Impact factor: 4.130

3.  Cellular localization of 1B236/myelin-associated glycoprotein mRNA during rat brain development.

Authors:  G A Higgins; H Schmale; F E Bloom; M C Wilson; R J Milner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

Review 4.  Differential expression of glial- and neuronal-associated antigens in human tumors of the central and peripheral nervous system.

Authors:  G Reifenberger; J Szymas; W Wechsler
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  An adherent subline of a unique small-cell lung cancer cell line downregulates antigens of the neural cell adhesion molecule.

Authors:  L A Doyle; M Borges; A Hussain; A Elias; T Tomiyasu
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

6.  Expression of oligodendroglia and Schwann cell markers in human nervous system tumors. An immunomorphological study and western blot analysis.

Authors:  K Schwechheimer; P Gass; H H Berlet
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

7.  Chronic inflammatory demyelinating polyneuropathy associated with metastatic malignant melanoma of unknown primary origin.

Authors:  José-Alberto Palma; Salvador Martín-Algarra
Journal:  J Neurooncol       Date:  2009-03-06       Impact factor: 4.130

Review 8.  Developmental and pathophysiological aspects of the myelin-associated glycoprotein.

Authors:  R O Brady; R H Quarles
Journal:  Cell Mol Neurobiol       Date:  1988-06       Impact factor: 5.046

9.  Myelin-associated glycoprotein (MAG) and rat brain-specific 1B236 protein: mapping of epitopes and demonstration of immunological identity.

Authors:  A B Noronha; J A Hammer; C Lai; M Kiel; R J Milner; J G Sutcliffe; R H Quarles
Journal:  J Mol Neurosci       Date:  1989       Impact factor: 3.444

10.  Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab.

Authors:  Lorraine Cafuir; David Lawson; Nilesh Desai; Vita Kesner; Alfredo Voloschin
Journal:  J Immunother Cancer       Date:  2018-01-30       Impact factor: 13.751

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.